Predicting and Taming Immunogenicity: Strategies for your Biologic Drug On-Demand Webinar Predicting and Taming Immunogenicity: Strategies for your Biologic Drug Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…CertaraNovember 19, 2021
Dose Optimization Using Population PK for an Orphan Drug Case Study Dose Optimization Using Population PK for an Orphan Drug RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…CertaraNovember 17, 2021
A Day in the Life of a Clinical Pharmacology Consultant Blog A Day in the Life of a Clinical Pharmacology Consultant Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…CertaraOctober 8, 2021
What does the Clinical Pharmacology Plan for a Biologic Look Like? On-Demand Webinar What does the Clinical Pharmacology Plan for a Biologic Look Like? Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…CertaraAugust 6, 2021
Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Blog Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…CertaraJuly 8, 2021
8 Tips for Successfully Developing Oligonucleotide Therapies Blog 8 Tips for Successfully Developing Oligonucleotide Therapies By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…CertaraFebruary 1, 2021
“Where do I start?”: Strategies for selecting the first dose for human clinical trials White Paper “Where do I start?”: Strategies for selecting the first dose for human clinical trials This guide to dose selection for first-in-human studies explains the conceptual framework, methods, and tools…CertaraDecember 22, 2020
Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Publication Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy CertaraApril 25, 2018
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…CertaraApril 13, 2018
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…CertaraMarch 16, 2018